Understanding the Future of Medicare Advantage: A 2026 Analysis & Methodology
Medicare Advantage (MA) is a growing and increasingly complex part of the medicare landscape. As you consider your healthcare options, understanding the trends and details of these plans is crucial. This analysis focuses on the medicare Advantage marketplace as it’s projected to look in 2026, building on ancient data and outlining our rigorous methodology.
Who We Are:
This research is brought to you by a team of experts at KFF – Meredith Freed,Jeannie Fuglesten Biniek,Nancy Ochieng,and Tricia Neuman – alongside self-reliant consultant Anthony Damico. We’re dedicated to providing clear, unbiased facts about health policy issues.
Examining the 2026 Medicare Advantage Landscape
Our projections indicate meaningful developments in the MA market. We’ve analyzed plan offerings, availability across states and counties, and the performance of various insurance firms. This allows us to provide a comprehensive view of what you can expect in 2026.
This analysis specifically focuses on individual medicare Advantage plans available during general enrollment. We do not include employer-sponsored plans in our findings. Special Needs Plans (snps) are included in overall plan counts, terminations, renewals, entries, and exits.
Our Data Sources & Methods: A Clear Approach
We believe in transparency. Hear’s a detailed look at how we conducted this analysis, ensuring you can trust our findings:
* Data Source: We utilized data files released by the Centers for Medicare & Medicaid Services (CMS). These include:
* Medicare Advantage plan landscape files (released annually in the fall).
* Monthly medicare Advantage enrollment data at the contract, plan, state, and county level.
* Quarterly medicare Advantage benefit package files.
* monthly data from the Medicare Enrollment Dashboard.
* Geographic Considerations: We excluded Connecticut from county-level analysis due to inconsistencies in FIPS codes between CMS datasets. Similarly, some Alaskan counties were excluded for the same reason.
* Enrollment Calculation: In 2022,we refined our methodology for calculating Medicare Advantage enrollment share.We now focus on beneficiaries eligible for MA – those with both Medicare Part A and part B – for a more accurate representation. This change is reflected in all data trending back to 2010.
* Plan Type Focus: This analysis concentrates solely on Medicare Advantage plans. we’ve excluded cost plans, PACE plans, Health Care Prepayment Plans (HCPPs), and Medicare Advantage Medical Partnership (MMP) plans to provide a focused view of the core MA market.This exclusion is consistent across all data presented as 2010.
* Plan Counting methodology: KFF uses overall plan counts, rather than plan segments. this means our counts may be lower than those reported by CMS, as segments allow insurers to offer variations of the same plan with differing benefits and cost-sharing in different areas.
important Considerations & Methodological Updates
It’s important to understand how our approach has evolved to ensure the most accurate and relevant information.
* Historical Data Consistency: We’ve adjusted our enrollment calculations and plan type definitions to maintain consistency across all years analyzed, allowing for meaningful trend comparisons.
* data Accuracy: We strive for accuracy, but data discrepancies can occur. Our methodology aims to minimize these and provide the most reliable insights possible.
State-Level Availability of Medicare Advantage Plans (2026)
(Datawrapper visualization showing availability of Medicare Advantage Plans and Insurers, by state, 2026)
This map illustrates the availability of Medicare Advantage plans and the number of insurers operating in each state as projected for 2026. You can see significant variation across the country, highlighting the importance of researching options specific to your location.
Looking Ahead:
The Medicare Advantage landscape is constantly evolving. We will continue to monitor these trends and provide you with the latest information to help you make informed decisions about your healthcare.
Disclaimer: this analysis provides general information and should not be considered personalized medical or financial advice. Always consult with a qualified
Worth a look